REGENOSCA
Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair. Regenosca brings regeneration over scarring with our medical devices.
REGENOSCA
Social Links:
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2019-01-10
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.regenosca.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
305.52 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Holtsch Med
Holtsch Med develops reliable medical devices and drugs for the prevention, diagnosis, and healing of diseases.
Oxford Medistress
Oxford Med has developed the CopingCapacityâ„¢ stress-monitoring system that provides the first direct and quantitative measurement of stress.
Current Employees Featured
Founder
Investors List
Venture Kick
Venture Kick investment in Pre Seed Round - Regenosca
Venture Kick
Venture Kick investment in Grant - Regenosca
Foundation for Technological Innovation (FIT)
Foundation for Technological Innovation (FIT) investment in Debt Financing - Regenosca
MassChallenge
MassChallenge investment in Non Equity Assistance - Regenosca
Official Site Inspections
http://www.regenosca.com
- Host name: leda.kreativmedia.ch
- IP address: 80.74.153.84
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Regenosca"
Regenosca – seamless tissue regeneration
Mar 4, 2019 · regenosca sa. Home; About; Technology; News; Contact; Regenosca creates unique bio-implants, enabling the body to attract and organise its own cells for seamless healing. Our TissueSpan technology forms a …See details»
Regenosca - Crunchbase Company Profile & Funding
Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair. Regenosca brings regeneration over scarring …See details»
Regenosca Company Profile 2024: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for Regenosca. Use the PitchBook Platform to explore the full profile.See details»
Regenosca SA - LinkedIn
We are thrilled to announce that our webpage has a brand-new look! ? Check it out here: www.regenosca.com Explore the fresh design, meet Regenosca's team, and discover our …See details»
Regenosca SA - BioAlps
Regenosca SA Share this actor Safe and body-friendly implant that allows surgeons to successfully reconstruct the bladder.See details»
Regenosca closes CHF 1Million pre-seed round - BioAlps
Nov 15, 2024 · Regenosca has successfully raised CHF 1 Million from private investors, Business Angels Switzerland, and Venture Kick. “This funding will allow us to demonstrate endoscopic …See details»
Regenosca SA Company Profile | Lausanne, VAUD, Switzerland ...
Find company research, competitor information, contact details & financial data for Regenosca SA of Lausanne, VAUD. Get the latest business insights from Dun & Bradstreet.See details»
Regenosca closes CHF 1M pre-seed round to demonstrate …
Foundation, and Venture Kick, Regenosca proudly welcomes this new group of investors. About: Regenosca (www.regenosca.com) is a regenerative medtech firm based in Lausanne that …See details»
Regenosca - Funding, Financials, Valuation & Investors - Crunchbase
Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair.See details»
Regenosca SA – Swiss Biotech
Discover if your new anti-cancer drug will work! Our validated platform uses intact patients tumors, maintains their complexity and cellular component, and overcomes organoids. This allows to …See details»
Fresh funding for Regenosca - startupticker.ch
Jul 26, 2024 · Regenosca, a Lausanne based startup developing non-invasive regenerative tissue implants, has closed a CHF 1M pre-seed round from private investors, Business Angels …See details»
Regenosca: The Venture Leaders Medtech developing a …
Aug 15, 2023 · With a primary focus on off-the-shelf and ready-to-use implants, the startup's innovative approach holds promise in soft tissue repair surgeries. Regenosca's patented …See details»
Regenosca - Overview, News & Similar companies | ZoomInfo.com
View Regenosca (www.regenosca.com) location in Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Regenosca SA. (7/22/24). "Press Release: Regenosca Closes CHF …
Regenosca (www.regenosca.com) is a regenerative medtech firm based in Lausanne that provides seamless tissue regeneration to solve today’s difficult clinical problems in a surgeon- …See details»
Regenosca - Contacts, Employees, Board Members, Advisors
Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair.See details»
Closing pre-seed round – Regenosca
Jul 24, 2024 · Regenosca closes CHF 1 million pre-seed round to demonstrate endoscopic delivery of TissueSpan implants. Lausanne, Switzerland – July 22, 2024 – Regenosca creates …See details»
Regenosca wins CHF 150,000 to improve the treatment options for …
Nov 27, 2020 · Regenosca will use the CHF 150,000 Venture Kick funding to manufacture a prototype to create first-in-man safety data and biocompatibility data. Regenosca has …See details»
Innosuisse recognizes startups envisioned to transform the …
Jun 6, 2024 · Regenosca – developed and patented the technology platform, called TissueSpan, which allows for the creation of off-the-shelf and ready-to-use implants that serve as a …See details»
Regenosca SA - Venture Kick
Jul 19, 2023 · Regenosca SA: Regenosca’s patented technology TissueSpan results in off-the-shelf and ready to use implants to avoid a second surgical site in soft tissue repair surgeries. …See details»
Regenosca - startup.ch
Regenosca: Regenosca’s patented technology TissueSpan results in off-the-shelf and ready to use implants to avoid a second surgical site in soft tissue repair surgeries. They are …See details»